Martin Shkreli, Insider at Retrophin, Inc. (RTRX), sold 1,172,000 shares at $8.41 ($10.4M) on 2014-11-21, disclosed to the SEC on 2014-11-24.
Open-market sale of $10.4M RTRX by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.23 | 100,000 | $1.0M | 9.9% |
| 2 | $9.41 | 100,000 | $941K | 9.1% |
| 3 | $9.19 | 254,975 | $2.3M | 22.6% |
| 4 | $8.54 | 329,824 | $2.8M | 27.2% |
| 5 | $8.23 | 134,354 | $1.1M | 10.7% |
| 6 | $8.41 | 252,847 |
| $2.1M |
| 20.5% |
| Total | $8.84 avg | 1,172,000 | $10.4M | 100% |
| Filing → |
| KBIO | BUY | 2015-11-23 | $94K | — | Filing → |
| KBIO | BUY | 2015-11-19 | $889K | — | Filing → |
| KBIO | BUY | 2015-11-18 | $1.6M | — | Filing → |